ImmuPharma (IMM) News Today GBX 13.80 +1.90 (+15.97%) As of 04:57 AM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock IMM Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period ImmuPharma (LON:IMM) Trading 15% Higher - Should You Buy?October 2, 2025 | marketbeat.comImmuPharma (LON:IMM) Shares Up 15% - Here's WhyOctober 2, 2025 | marketbeat.comImmuPharma (LON:IMM) Shares Up 15% - Here's What HappenedOctober 1, 2025 | marketbeat.comImmuPharma (LON:IMM) Trading Up 15% - What's Next?October 1, 2025 | marketbeat.comImmuPharma (LON:IMM) Trading 15% Higher - Time to Buy?October 1, 2025 | marketbeat.comImmuPharma (LON:IMM) Stock Price Up 15% - What's Next?October 1, 2025 | marketbeat.comImmuPharma (LON:IMM) Stock Price Up 15% - Here's WhyOctober 1, 2025 | marketbeat.comImmuPharma (LON:IMM) Trading Up 13.3% - Still a Buy?October 1, 2025 | marketbeat.comImmuPharma (LON:IMM) Stock Price Up 28.6% - Still a Buy?October 1, 2025 | marketbeat.comImmuPharma (LON:IMM) Trading Up 28.6% - Should You Buy?October 1, 2025 | marketbeat.comImmuPharma (LON:IMM) Stock Price Up 28.6% - Time to Buy?October 1, 2025 | marketbeat.comImmuPharma (LON:IMM) Stock Price Up 28.6% - Should You Buy?October 1, 2025 | marketbeat.comImmuPharma (LON:IMM) Trading 28.6% Higher - Here's What HappenedOctober 1, 2025 | marketbeat.comImmuPharma (LON:IMM) Trading Up 28.6% - Still a Buy?September 30, 2025 | marketbeat.comImmuPharma (LON:IMM) Stock Price Up 28.6% - What's Next?September 30, 2025 | marketbeat.comImmuPharma (LON:IMM) Trading Up 28.6% - Time to Buy?September 30, 2025 | marketbeat.comImmuPharma (LON:IMM) Trading Up 28.6% - What's Next?September 30, 2025 | marketbeat.comImmuPharma (LON:IMM) Trading 28.6% Higher - Still a Buy?September 30, 2025 | marketbeat.comImmuPharma (LON:IMM) Shares Up 28.6% - What's Next?September 30, 2025 | marketbeat.comImmuPharma (LON:IMM) Shares Up 28.6% - Should You Buy?September 30, 2025 | marketbeat.comImmuPharma (LON:IMM) Trading 28.6% Higher - Here's WhySeptember 30, 2025 | marketbeat.comImmuPharma (LON:IMM) Shares Up 28.6% - Here's WhySeptember 30, 2025 | marketbeat.comImmuPharma (LON:IMM) Shares Up 30.1% - Here's What HappenedSeptember 30, 2025 | marketbeat.comImmuPharma (LON:IMM) Trading 30.7% Higher - Should You Buy?September 30, 2025 | marketbeat.comImmuPharma (LON:IMM) Trading 28% Higher - Time to Buy?September 30, 2025 | marketbeat.comImmuPharma (LON:IMM) Trading Up 33.2% - Here's What HappenedSeptember 30, 2025 | marketbeat.comImmuPharma (LON:IMM) Shares Up 36.5% - Should You Buy?September 30, 2025 | marketbeat.comImmuPharma (LON:IMM) Trading 36.5% Higher - Time to Buy?September 30, 2025 | marketbeat.comImmuPharma (LON:IMM) Trading Up 21.5% - Here's WhySeptember 30, 2025 | marketbeat.comImmuPharma (LON:IMM) Trading Up 25.4% - Here's WhySeptember 30, 2025 | marketbeat.comImmuPharma (LON:IMM) Stock Price Up 25.4% - Still a Buy?September 30, 2025 | marketbeat.comMeet the 10p penny stock that’s outperformed global stock markets this month!September 30, 2025 | msn.comImmuPharma (LON:IMM) Stock Price Down 6.1% - What's Next?September 25, 2025 | marketbeat.comImmuPharma (LON:IMM) Trading Down 9.9% - Here's WhySeptember 25, 2025 | marketbeat.comImmuPharma (LON:IMM) Trading Down 9.9% - Should You Sell?September 25, 2025 | marketbeat.comImmuPharma (LON:IMM) Stock Price Down 9.9% - Time to Sell?September 25, 2025 | marketbeat.comImmuPharma (LON:IMM) Trading Down 9.9% - What's Next?September 24, 2025 | marketbeat.comImmuPharma (LON:IMM) Stock Price Down 9.9% - Here's What HappenedSeptember 24, 2025 | marketbeat.comImmuPharma (LON:IMM) Shares Down 9.9% - Should You Sell?September 24, 2025 | marketbeat.comImmuPharma (LON:IMM) Stock Price Down 9.9% - Here's WhySeptember 24, 2025 | marketbeat.comImmuPharma (LON:IMM) Stock Price Down 9.9% - What's Next?September 24, 2025 | marketbeat.comImmuPharma (LON:IMM) Shares Down 9.9% - What's Next?September 24, 2025 | marketbeat.comImmuPharma (LON:IMM) Stock Price Down 2.5% - Here's WhySeptember 24, 2025 | marketbeat.comImmuPharma (LON:IMM) Trading Down 10% - Time to Sell?September 24, 2025 | marketbeat.comImmuPharma (LON:IMM) Shares Down 6.1% - What's Next?September 24, 2025 | marketbeat.comImmuPharma (LON:IMM) Trading Down 1.7% - Here's WhySeptember 24, 2025 | marketbeat.comImmuPharma (LON:IMM) Stock Price Down 1.7% - Here's WhySeptember 24, 2025 | marketbeat.comImmuPharma (LON:IMM) Trading Down 3.5% - What's Next?September 24, 2025 | marketbeat.comImmuPharma (LON:IMM) Trading Down 3.5% - Time to Sell?September 24, 2025 | marketbeat.comImmuPharma (LON:IMM) Stock Price Down 3.7% - What's Next?September 24, 2025 | marketbeat.com Get ImmuPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for IMM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IMM Media Mentions By Week IMM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMM News Sentiment▼0.320.54▲Average Medical News Sentiment IMM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMM Articles This Week▼325▲IMM Articles Average Week Get the Latest News and Ratings for IMM and Related Stocks Enter your email address to receive the latest news and analysts' ratings for ImmuPharma and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies FARN News BVXP News 4BB News SCLP News HVO News HEMO News SBTX News SAR News AREC News POLB News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:IMM) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersThe $20 stock that could make silicon chips obsolete$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGet my No. 1 gold stock nowGold recently broke past $3,800 per ounce – setting yet another new all-time high. And Wall Street banks sa...Stansberry Research | SponsoredU.S. Government Sparking Crypto RallyAltcoin ETFs could surge prices (do this now) My "Crypto Bull Run Millionaire Blueprint" breaks down exactl...Crypto 101 Media | SponsoredAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmuPharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmuPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
